SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101 | -50.7% | 42,609 | 0.0% | 0.00% | – |
| Q2 2023 | $205 | +33.1% | 42,609 | +57.3% | 0.00% | – |
| Q1 2023 | $154 | +541.7% | 27,091 | +543.0% | 0.00% | – |
| Q4 2022 | $24 | -99.9% | 4,213 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | +92.9% | 4,213 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -56.2% | 4,213 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | -8.6% | 4,213 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | +20.7% | 4,213 | 0.0% | 0.00% | – |
| Q3 2021 | $29,000 | -71.0% | 4,213 | 0.0% | 0.00% | – |
| Q2 2021 | $100,000 | +16.3% | 4,213 | 0.0% | 0.00% | – |
| Q1 2021 | $86,000 | -16.5% | 4,213 | 0.0% | 0.00% | – |
| Q4 2020 | $103,000 | +123.9% | 4,213 | -37.8% | 0.00% | – |
| Q1 2019 | $46,000 | +53.3% | 6,778 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | – | 6,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |